Tessa Therapeutics Receives PRIME Designation from European Medicines Agency for CD30 CAR-T Therapy
Tessa Therapeutics today announced that the European Medicines Agency (EMA) has granted PRiority MEdicines (PRIME)…
Continue ReadingTessa Therapeutics today announced that the European Medicines Agency (EMA) has granted PRiority MEdicines (PRIME)…
Continue ReadingExcerpt Publication 2 Sample Excerpt
Continue ReadingExcerpt Publication 2 Sample Excerpt
Continue ReadingMr. McIntyre brings over 25 years of global financial, operational and legal experience, including over…
Continue ReadingExcerpt Publication 2 Sample Excerpt
Continue ReadingExcerpt Publication 2 Sample Excerpt
Continue Reading